A recent phase 3 clinical trial published in Annals of Internal Medicine supports the use of canagliflozin for treating type 2 diabetes in children and adolescents. The study involved 171 participants aged 10-18 years with inadequate glycemic control, who received either oral canagliflozin or a placebo for 52 weeks.
Continue reading “Phase 3 study supports use of canagliflozin for type 2 diabetes in children and adolescents”News
Latest Cures for Chilblains in Diabetes
Chilblains, also known as perniosis, are a common condition characterized by inflammation of small blood vessels in response to cold temperatures. People with diabetes are particularly susceptible to chilblains due to impaired blood circulation and neuropathy. Effective treatment of chilblains in individuals with diabetes requires a comprehensive approach that addresses both the symptoms and underlying causes.
Continue reading “Latest Cures for Chilblains in Diabetes”